Results 71 to 80 of about 477,894 (133)

Transfer of antiretroviral drugs into breastmilk: a prospective study from the Swiss Mother and Child HIV Cohort Study. [PDF]

J Antimicrob Chemother, 2022
Aebi-Popp K, Kahlert CR, Crisinel PA, Decosterd L, Saldanha SA, Hoesli I, Martinez De Tejada B, Duppenthaler A, Rauch A, Marzolini C, Swiss Mother and Child HIV Cohort Study (SHCS).   +10 more
europepmc   +1 more source

Review on fluorinated nucleoside/non-nucleoside FDA-approved antiviral drugs. [PDF]

RSC Adv, 2022
Ismail MMF, Ayoup MS.
europepmc   +1 more source

Effectiveness and safety of dolutegravir and raltegravir for treating children and adolescents living with HIV: a systematic review. [PDF]

J Int AIDS Soc, 2022
Townsend CL, O'Rourke J, Milanzi E, Collins IJ, Judd A, Castro H, Vicari M, Jesson J, Leroy V, Renaud F, Penazzato M.   +10 more
europepmc   +1 more source

Raltegravir-based Postnatal HIV Prophylaxis Therapy in a Neonate After in Utero Dolutegravir Exposure. [PDF]

Pediatr Infect Dis J, 2022
Jacobs TG, van Aerde KJ, Colbers A, Burger DM.   +3 more
europepmc   +1 more source

Adipocyte differentiation of 3T3-L1 cells under tenofovir alafenamide, tenofovir disoproxil fumarate, and integrase strand transfer inhibitors selective challenge: an in-vitro model. [PDF]

AIDS, 2023
Perna A, Carleo MA, Mascolo S, Guida A, Contieri M, Sellitto C, Hay E, De Blasiis P, Lucariello A, Guerra G, Baldi A, De Luca A, Maggi P, Esposito V.   +13 more
europepmc   +1 more source

Repurposing raltegravir for reducing inflammation and treating cancer: a bioinformatics analysis. [PDF]

Sci Rep
Nikfarjam Z, Rakhshi R, Zargari F, Aalikhani M, Hasan-Abad AM, Bazi Z.   +5 more
europepmc   +1 more source

HIV-1 subtype F integrase polymorphisms external to the catalytic core domain contribute to severe loss of replication capacity in context of the integrase inhibitor resistance mutation Q148H. [PDF]

J Antimicrob Chemother, 2022
Aulicino PC, Momin Z, Rozenszajn M, Monzon A, Arazi-Caillaud S, Bologna R, Mangano A, Kimata JT.   +7 more
europepmc   +1 more source

Efficacy of Integrase Strand Transfer Inhibitors and the Capsid Inhibitor Lenacapavir against HIV-2, and Exploring the Effect of Raltegravir on the Activity of SARS-CoV-2. [PDF]

Viruses
Kiarie IW, Hoffka G, Laporte M, Leyssen P, Neyts J, Tőzsér J, Mahdi M.   +6 more
europepmc   +1 more source

High Instantaneous Inhibitory Potential of Bictegravir and the New Spiro-β-Lactam BSS-730A for HIV-2 Isolates from RAL-Naïve and RAL-Failing Patients. [PDF]

Int J Mol Sci, 2022
Bártolo I, Moranguinho I, Gonçalves P, Diniz AR, Borrego P, Martin F, Figueiredo I, Gomes P, Gonçalves F, Alves AJS, Alves N, Caixas U, Pinto IV, Barahona I, Pinho E Melo TMVD, Taveira N.   +15 more
europepmc   +1 more source

Expression of HIV from a 1-LTR circular DNA in the absence of integration. [PDF]

Retrovirology
Gurgo C, Fenizia C, McKinnon K, Hsia RC, Franchini G.   +4 more
europepmc   +1 more source